Related Experiment Video
Updated: Jul 18, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Management of difficult germ-cell tumors
Christie J Moore1, Siamak Daneshmand, G Varuni Kondagunta
1Department of Medicine, Division of Hematology/Oncology, Oregon Health and Science University, Portland, Oregon, USA.
Testicular cancer is highly curable, with over 95% of patients achieving remission. This review highlights diagnostic challenges in managing testicular cancer, focusing on relapse detection in patients with elevated tumor markers or residual abnormalities.
Area of Science:
- Oncology
- Urology
Background:
- Testicular cancer is a rare neoplasm, comprising 1% of male cancers.
- It is a highly curable malignancy with over 95% cure rates.
- Effective management requires awareness of diagnostic and therapeutic challenges, especially regarding relapse determination.
Purpose of the Study:
- To review the evaluation and management of testicular cancer patients.
- To highlight pitfalls in determining relapse in testicular cancer.
- To discuss the approach to persistent elevation of serum tumor markers and residual radiographic abnormalities post-chemotherapy.
Main Methods:
- Case series review.
- Evaluation of persistent serum tumor markers.
- Assessment of post-chemotherapy radiographic abnormalities.
Main Results:
- Testicular cancer demonstrates high curability with appropriate management.
- Challenges exist in accurately determining relapse, particularly with persistent tumor markers or imaging findings.
- Early recognition and management of these challenges are crucial for successful outcomes.
Conclusions:
- Testicular cancer is a curable malignancy requiring specialized knowledge for optimal care.
- Clinicians must be vigilant for pitfalls in relapse assessment.
- Management strategies for persistent tumor markers and radiographic abnormalities are critical for patient cure.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
